CHU de Clermont-Ferrand — Clermont-Ferrand

Public research footprint of CHU de Clermont-Ferrand, compiled from the ClinicalTrials.gov public registry.

484

Registered studies

155

Active

Recruiting now

203

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · Relapsed/Refractory Follicular Lymphoma · Progressive Multiple Sclerosis (PMS) · Leukemia, Myeloid, Acute

Recently updated registry entries

NCT04887077 — Digital Intervention Promoting Physical Activity Among Obese People (DIPPAO) (Completed)
NCT04391452 — Dietary Supplement With Magnesium, Vitamins, Rhodiola and L-theanine Stressed Subjects… (Completed)
NCT01390623 — Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Clermont-Ferrand?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.